CyberKnife stereotactic ablative radiotherapy (SABR) in patients with non-small cell lung cancer ( NSCLC)

被引：0
|
作者：
Leschenko, Y. [1 ]
Chebotareva, T. [1 ]
Spizhenko, N. [1 ]
Fedusenko, A. [1 ]
Sharaevskiy, O. [1 ]
Buryk, V. [1 ]
机构：
[1] Cyber Knife, Cyber Clin Spizhenko, Kapitanivka, Kyiv Region, Ukraine
来源：
RADIOTHERAPY AND ONCOLOGY | 2014年 / 111卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-1155
引用
收藏
页码：S39 / S39
页数：1
相关论文
共 50 条
  • [41] Improved survival with stereotactic ablative radiotherapy (SABR) over lobectomy for early stage non-small cell lung cancer (NSCLC): addressing the fallout of disruptive randomized data
    Rusthoven, Chad G.
    Kavanagh, Brian D.
    Karam, Sana D.
    ANNALS OF TRANSLATIONAL MEDICINE, 2015, 3 (11)
  • [42] Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: Exploration of clinical indications
    Li, Qiaoqiao
    Swanick, Cameron W.
    Allen, Pamela K.
    Gomez, Daniel R.
    Welsh, James W.
    Liao, Zhongxing
    Balter, Peter A.
    Chang, Joe Y.
    RADIOTHERAPY AND ONCOLOGY, 2014, 112 (02) : 256 - 261
  • [43] Clinical Outcome of Fiducial-Less CyberKnife Stereotactic Ablative Body Radiotherapy for Stage I Non-Small Cell Lung Cancer
    Jung, Inhye
    Song, Si Yeol
    Jung, Jinhong
    Cho, Byungchul
    Kwak, Jungwon
    Je, Hyoung Uk
    Choi, Wonsik
    Jung, Nuri H.
    Cho, Eun Kyung
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S566 - S566
  • [44] Selection of patients for stereotactic lung radiotherapy (SBRT) for early stage non-small cell lung cancer (NSCLC)
    Pearson, S.
    Franks, K.
    Pearson, S.
    Purdie, T.
    Bissonnette, JI-P.
    Cho, J.
    Sun, A.
    Kane, G.
    Payne, D.
    Bezjak, A.
    RADIOTHERAPY AND ONCOLOGY, 2006, 80 : S51 - S52
  • [45] Adjuvant Stereotactic Ablative Radiation therapy (SABR) for Resected Non-Small Cell Lung Cancer With Positive Margins
    Bhatt, N. H.
    Van Berkel, V.
    Bousamra, M.
    Woo, S. Y.
    Dunlap, N. E.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : E390 - E390
  • [46] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-Small Cell Lung Cancer (NSCLC). A UK Randomized Phase III Trial
    Ngai, Yenting
    Hanna, Gerard
    Conibear, John
    Counsell, Nicholas
    Hughes, Laura
    Farrelly, Laura
    Landau, David
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1425 - S1426
  • [47] SARON: Stereotactic Ablative Radiotherapy for Oligometastatic Non-small cell lung cancer (NSCLC). A UK randomised phase III trial
    Landau, D. B.
    Hughes, L.
    Ngai, Y.
    Hanna, G. G.
    Conibear, J.
    Farrelly, L.
    Counsell, N.
    LUNG CANCER, 2017, 103 : S54 - S54
  • [48] Feasibility of stereotactic ablative radiotherapy for locally-advanced non-small cell lung cancer
    Woodford, K.
    Panettieri, V.
    Le, T. Tran
    Senthi, S.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S555 - S556
  • [49] Response to stereotactic ablative radiotherapy in a novel orthotopic model of non-small cell lung cancer
    Oweida, Ayman
    Sabri, Siham
    Al-Rabea, Areej
    Ebrahimi, Mojgan
    Ruo, Russel
    Fraser, Richard
    Seuntjens, Jan
    Abdulkarim, Bassam
    ONCOTARGET, 2018, 9 (02) : 1630 - 1640
  • [50] Stereotactic ablative radiotherapy for early stage non-small cell lung cancer: a word of caution
    Varela, Gonzalo
    Teresa Gomez-Hernandez, Maria
    TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) : 102 - 105
12345